Acacia research corp (ACTG)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Revenues

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues

-

11,246

59,761

71,775

-

131,506

85,761

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenues

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

250,727

205,258

220,904

210,166

172,256

164,563

177,927

153,187

131,829

0

0

0

Portfolio operations:
Inventor royalties

4,017

4,944

15,754

16,159

14,777

35,168

24,179

22,998

26,030

4,952

8,252

0

0

0

-

-

-

18,462

15,064

19,615

29,044

20,670

19,592

17,278

12,194

29,724

30,273

32,952

36,915

26,028

28,657

39,217

38,232

43,727

41,265

40,181

34,470

25,292

0

0

0

Contingent legal fees

648

591

12,343

15,257

15,919

31,501

20,391

29,615

31,814

16,682

20,274

0

0

0

-

-

-

16,169

19,564

25,255

26,820

23,563

19,448

14,332

11,279

24,784

27,066

33,352

35,935

24,651

24,735

28,230

34,662

40,281

37,029

34,440

24,866

19,906

0

0

0

Patent acquisition expenses

-

0

0

0

-

4,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patent acquisition expenses

-

-

-

-

-

-

-

-

-

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patent acquisition expenses

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Litigation and licensing expenses - patents

5,039

7,803

8,332

8,894

9,678

8,866

10,803

13,327

14,822

18,219

20,056

0

0

0

-

-

-

39,373

36,240

35,487

37,295

37,614

38,305

39,583

38,681

39,335

37,405

32,508

27,858

21,591

16,827

14,355

12,848

13,005

13,727

13,061

13,733

13,891

0

0

0

Amortization of patents

3,581

3,194

13,897

17,986

22,446

27,120

21,003

21,676

21,969

22,154

22,933

0

0

0

-

-

-

53,067

52,750

52,573

54,877

53,745

57,684

56,788

53,834

53,658

55,011

52,808

45,623

39,019

22,358

13,892

11,099

9,745

9,707

9,724

9,000

6,931

0

0

0

Other portfolio expenses (income)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total portfolio expenses

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of Goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

30,149

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other portfolio expenses

-

1,756

575

3,252

-

2,602

3,402

1,200

0

0

0

-

0

0

-

-

-

4,141

3,891

1,974

1,974

1,548

1,548

3,506

3,506

3,506

3,506

0

0

-

0

-

-

-

-

-

-

-

-

-

-

Total portfolio expenses

-

18,288

50,901

61,548

-

109,257

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net portfolio income (loss)

-2,483

-7,042

8,860

10,227

6,728

22,249

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Verdict insurance proceeds

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

12,451

12,451

0

0

0

0

0

0

Verdict insurance proceeds related costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

7,661

7,661

0

0

0

0

0

0

General and administrative expenses

17,599

16,376

14,802

16,027

19,180

18,826

15,932

22,792

22,610

26,545

35,741

0

0

0

-

-

-

38,176

41,648

43,842

47,436

48,554

50,498

57,097

57,100

59,251

61,798

55,477

54,196

54,083

46,210

43,044

39,443

35,693

33,322

30,962

28,716

25,067

0

0

0

Research, consulting and other expenses - business development

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-

-

3,391

3,168

3,574

3,845

3,840

3,945

3,467

3,190

3,229

3,208

3,617

4,858

4,943

5,667

5,378

4,746

4,338

3,728

3,339

2,457

2,121

0

0

0

Impairment of Intangible Assets (Excluding Goodwill)

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of patent-related intangible assets

-

0

0

0

-

28,210

28,210

0

0

0

-

-

0

0

-

-

-

74,731

931

931

931

3,497

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net portfolio income (loss)

-2,483

-7,042

8,860

10,227

6,728

22,249

1,983

0

0

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total operating costs and expenses

-

-

-

-

-

-

-

-

-

-

0

0

-

0

-

-

-

277,659

173,256

183,251

202,222

193,031

193,586

194,617

182,350

213,487

218,267

210,714

205,385

170,315

144,454

139,326

136,240

141,999

133,988

131,707

113,242

93,208

0

0

0

Operating loss

-20,082

-23,418

-5,942

-5,800

-40,662

-24,787

-42,159

-37,638

-6,726

-27,272

-28,997

0

0

0

-

-

-

-152,622

-54,686

-40,483

-49,714

-62,155

-78,675

-101,378

-116,077

-82,931

-36,512

-9,540

23,163

80,412

60,804

81,578

73,926

30,257

30,575

46,220

39,945

38,621

0

0

0

Other income (expense):
Gain on Conversion of Loan and Accrued Interest

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on exercise of Primary Warrant

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of investment, net (Note 5)

7,099

9,899

0

0

0

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on sale of investment (Note 5)

6,956

9,230

0

0

0

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of the Series A and B warrants and embedded derivative

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of trading securities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (loss) on sale of trading securities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income (Loss) from Equity Method Investments

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investment Income, Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

482

0

0

0

-

-

-

-

-

-

-

-

Write off of investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Interest income and other

-

-

-

-

-

-

-

-

-

-101,527

2,015

0

0

0

-

-

-

-56

-507

-384

-476

-595

17

354

950

2,131

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

Interest income and other

5,137

5,473

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net realized gain (loss) on investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Total other income (expense)

-7,416

4,465

-22,468

-47,560

-35,171

-78,882

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Interest and investment income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

135

0

0

0

Loss before income taxes

-27,498

-18,953

-28,410

-53,360

-75,833

-103,669

-202,979

-11,836

3,599

24,639

126,456

0

0

0

-

-

-

-152,678

-55,193

-40,867

-50,190

-62,750

-78,658

-101,024

-115,127

-80,800

-33,722

-7,071

25,334

81,349

60,939

81,779

74,049

30,353

30,705

46,369

40,090

38,756

0

0

0

Income tax benefit (expense)

-3,476

-1,824

720

1,026

1,302

1,179

802

712

1,905

2,955

5,349

0

0

0

-

-

-

4,800

1,076

884

5,454

3,912

6,852

-12,863

-26,602

-21,958

-19,591

-1,959

10,585

22,060

15,668

19,495

16,307

8,708

10,458

8,886

8,567

1,740

0

0

0

Net loss including noncontrolling interests in subsidiaries

-24,022

-17,129

-29,130

-54,386

-77,135

-104,848

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Business Acquisition, Pro Forma Provision for Income Taxes

-3,476

-1,824

720

1,026

1,302

1,179

802

712

1,905

2,955

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,740

0

0

0

Net loss including noncontrolling interests in subsidiaries

-

-

-

-

-

-

-

-

-

21,684

121,107

0

0

0

-

-

-

-157,478

-56,269

-41,751

-55,644

-66,662

-85,510

-88,161

-88,525

-58,842

-14,131

-5,112

14,749

59,289

45,271

62,284

57,742

21,645

20,247

37,483

31,523

37,016

0

0

0

Net (income) loss attributable to noncontrolling interests in subsidiaries

0

-14

-12

319

240

181

82

-345

-278

-496

-665

0

0

0

-

-

-

2,558

4,101

3,724

-906

-633

-2,392

-1,747

-2,557

-2,408

-853

-926

111

-164

-170

-579

-939

539

222

3,586

3,631

2,965

0

0

0

Business Acquisition, Pro Forma Net (Income) Loss Attributable to Noncontrolling Interests

0

-14

-12

319

240

181

82

-345

-278

-496

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,965

0

0

0

Net loss attributable to Acacia Research Corporation

-24,022

-17,115

-29,118

-54,705

-77,375

-105,029

-203,863

-12,203

1,972

22,180

121,772

0

0

0

-

-

-

-160,036

-60,370

-45,475

-54,738

-66,029

-83,118

-86,414

-85,968

-56,434

-13,278

-4,186

14,638

59,453

45,441

62,863

58,681

21,106

20,025

33,897

27,892

34,051

0

0

0

Less: Dividend on Series A redeemable convertible preferred stock

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less: Accretion of Series A redeemable convertible preferred stock

938

307

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders - basic and diluted

-25,223

-17,422

-29,118

-54,705

-77,375

-105,029

64,666

83,609

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Basic net loss per share of common stock

-

0.01

-0.15

-0.12

-

-0.23

-0.67

-0.57

-0.63

-

3.13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.69

-0.33

-0.26

0.10

0.20

-0.14

0.13

1.13

-0.10

0.26

0.05

0.35

-0.16

0.75

-0.12

0.60

Weighted average number of shares outstanding - basic

-

49,875

49,828

49,696

-

49,639

49,557

50,061

50,632

-

50,554

-

-

-

-

-

-

-

-

-

-

-

-

-

-

48,415

48,330

48,008

47,859

48,335

48,332

47,944

44,367

41,418

41,292

40,994

35,182

33,879

32,794

31,664

30,847

Less: Accretion of redeemable preferred stock

938

307

0

0

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less: Mark-to-market adjustment for preferred stock embedded derivative

-

-3,258

0

0

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net loss per common share

-0.24

-

-0.16

-0.11

-0.09

-

-

-

-

-2.18

-

-0.28

-0.24

-0.21

-

-

-

-2.33

-0.55

-0.08

-0.27

-0.34

-0.26

-0.27

-0.51

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to common stockholders - diluted

-

-20,373

-29,118

-54,705

-

-105,029

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

Diluted net loss per share of common stock

-

-0.05

-0.15

-0.12

-

-0.23

-0.67

-0.57

-0.63

-

3.13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.69

-0.33

-0.26

0.10

0.20

-0.14

0.13

1.09

-0.10

0.25

0.05

0.34

-0.16

0.70

-0.12

0.55

Weighted average number of shares outstanding - diluted

-

54,406

49,828

49,696

-

49,639

49,557

50,061

50,632

50,590

50,599

-

50,333

-

-

-

-

-

-

-

-

-

-

-

-

48,415

48,330

48,008

48,104

48,797

48,641

48,938

45,771

41,418

42,857

42,453

36,448

33,879

35,105

31,664

33,411

Weighted average number of shares outstanding - basic and diluted

49,875

-

49,830

49,696

49,655

-

-

-

-

-

-

50,499

-

50,237

-

-

-

49,749

49,630

49,423

49,212

48,944

48,806

48,543

48,329

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative expenses(1)

17,599

16,376

14,802

16,027

19,180

18,826

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative expenses excluding share-based compensation

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash stock compensation general and administrative

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash stock compensation - profits interests

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash stock compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-